Newton, MA, United States of America

Robert Flaumenhaft

USPTO Granted Patents = 7 

Average Co-Inventor Count = 2.6

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Newton, MA (US) (2007 - 2018)
  • Boston, MA (US) (2024)

Company Filing History:


Years Active: 2007-2025

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Robert Flaumenhaft

Introduction

Robert Flaumenhaft is a notable inventor based in Newton, MA, who has made significant contributions to the field of medical science. With a total of seven patents to his name, Flaumenhaft has focused on developing innovative methods and compositions aimed at treating serious health conditions.

Latest Patents

Among his latest patents is a method for treating sickle cell disease using quercetin-containing compositions. This invention discloses compositions and methods for treating sickle cell disease, including the administration of isoquercetin, vitamin B3, vitamin C, and optionally folic acid. The effective amount of these components is designed to halt the progression of one or more symptoms of sickle cell disease. Another significant patent involves methods for reducing major thrombotic events in cancer patients. This invention relates to methods aimed at reducing soluble P-selectin and major thrombotic events, which are critical concerns in cancer treatment.

Career Highlights

Flaumenhaft has worked with prestigious institutions such as Beth Israel Deaconess Medical Center and The Broad Institute. His work in these organizations has allowed him to contribute to groundbreaking research and development in the medical field.

Collaborations

Throughout his career, Flaumenhaft has collaborated with esteemed colleagues, including Jeffrey I. Zwicker and Bruce Furie. These collaborations have further enhanced his research and innovation efforts.

Conclusion

Robert Flaumenhaft's contributions to medical science through his patents and collaborations highlight his commitment to improving health outcomes. His innovative approaches to treating sickle cell disease and reducing thrombotic events in cancer patients demonstrate the impact of his work in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…